Feedback / Questions
NMT.001 - NEUmiRNA Therapeutics
https://www.globenewswire.com/news-release/2025/01/08/3005968/0/en/Angelini-Ventures-co-leads-20-million-Series-A-financing-in-Neumirna-Therapeutics-to-Develop-Next-Generation-RNA-Therapeutics-for-Epilepsy-and-other-Neurological-Disorders.html
 
Jan 8, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious